Breaking News With Anil Singhvi: Boost for Aarti Drugs as import duty slapped on Ciprofloxacin | share price target Rs 848
Breaking News With Anil Singhvi: Zee Business correspondent Chetan Bhutani has said that the Government of India has issued a final notification on one drug which is used to cure many infections. The drug is called Ciprofloxacin Hydrochloride. Now official notification has been imposed on Ciprofloxacin Hydrochloride for 5 years and an official announcement has been made related to this decision.
Breaking News With Anil Singhvi: Zee Business correspondent Chetan Bhutani has said that the Government of India has issued a final notification on one drug which is used to cure many infections. The drug is called Ciprofloxacin Hydrochloride. Now official notification has been imposed on Ciprofloxacin Hydrochloride for 5 years and an official announcement has been made related to this decision. Aarti Drugs share price today is Rs 692, up Rs 21 or 3.2%.
From January 2020, this drug was under investigation as it was coming from China. This decision will benefit Aarti Drugs the most.
See Zee Business Live TV Streaming Below:
Aarti Drugs is the sole producer of this drug. Siddharth Sedani said that this was a long pending problem for Aarti Drugs. He said if the Anti Dumping restrictions are being imposed then it will benefit Aarti Drugs the most.
This is a API Segment based company and the fundamentals of the company are extremely strong. Siddharth said they have a target of Rs 848 on Aarti Drugs in 1 year. The stock has consolidated for some time and now it seems ready for an upmove.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.